Springboard is acquired by Sanner Group
Springboard, an expert in the design and development of medical devices for regulated markets, has been acquired by Sanner Group, a manufacturer of healthcare packaging and a medical device Contract Development and Manufacturing Organization (CDMO).
The purchase of Springboard is consistent with Sanner Group’s objective to develop a portfolio of services for its clients in the medical device, diagnostic, and drug delivery industries. With the help of Springboard, Sanner Group will be able to develop medical devices internally and open a new Design Center of Excellence in the UK.
From being the industry leader in desiccant closures and effervescent tablet packaging, Sanner Group has developed into a highly sought-after supplier of customized solutions for the pharmaceutical, medical technology, and diagnostic industries , and consumer healthcare,” stated Hans-Willem van Vliet, CEO of Sanner Group. By providing our clients with extensive knowledge and assistance throughout the whole medical device development process—from initial concept design to commercial manufacturing—the acquisition of Springboard enhances this offering even more.
“Springboard is a highly complementary acquisition due to its strong reputation for providing exceptional concept through to manufacture design services, as well as its ability to solve complex technical and scientific problems for its customers combined with an excellent culture. We are eager to have the Springboard team join the Sanner Group and to continue providing excellence throughout the whole product lifecycle.
With a full range of engineering, multidisciplinary scientific skills, and engineering capabilities, Springboard develops devices from an initial concept to manufacture, providing a comprehensive service for both pre- and post-product launch. With 30 employees and in-house expertise in physics, electronics, software, and materials science, the company is renowned for producing regulated devices at a reasonable cost that yield valuable intellectual property for clients. Springboard is an expert in the fields of respiratory, surgical, critical care, implantables, diagnostics, and biotechnology. It also provides equipment and consumables for these areas. Drug delivery devices include autoinjectors, infusion pumps, inhalers, and syringes.
With the world’s largest portfolio of effervescent products, Sanner Group is constructing a next-generation device-CDMO that blends agility and astute thinking with a long history in the active primary healthcare packaging sector. A key component of Sanner Group’s plan to strengthen its CDMO operations in the field of medical technology and diagnostics is the acquisition of Springboard. The center of this will be the new Design Center of Excellence by Sanner Group.
Tom Oakley, director of Springboard, said, “We are thrilled to join Sanner Group to form its Design Center of Excellence for medical device development.” In addition to having access to design innovation based on superior scientific and engineering capabilities, our clients—which range in size from the biggest multinational corporations to the fastest-growing start-ups—will also gain from integrated design for manufacturing. From small-scale production for clinical trials and verification to full-scale serial production within the Sanner Group’s global manufacturing facilities, we can support any project.
“Our combination with Sanner Group brings world-class intelligent healthcare solutions to our clients and is a major step in our growth journey,” said Keith Turner, director of Springboard. Sanner and Springboard are thrilled to be working together to achieve our shared goal of bettering people’s lives all around the world.
Alvarez & Marsal provided financial advice to the Sanner Group, Deloitte provided tax structuring advice, and Norton Rose Fulbright provided legal advice.